Brief: Theseus Pharmaceuticals Q1 net loss USD 14.586 million
11/05/2023 12:13
May 11 (Reuters) - Theseus Pharmaceuticals Q1 operating expenses USD 17.055 million. * Q1 income from operations USD -17.055 million * Q1 EPS USD -0.34 * Q1 net income USD -14.586 million
Recent news on Theseus Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Cidara Therapeutics, Senti Bio, Lumentum Holdings
U.S. STOCKS ON THE MOVE-Newmont Corp, Ansys, Karuna Therapeutics
Theseus Pharma rises as Concentra Biosciences agrees to take it private
Brief: Theseus Pharmaceuticals To Be Acquired by Concentra Biosciences
Brief: Theseus Pharmaceuticals Inc Says As Part Of A Reduction In Workforce, Co Terminated Employment Of Timothy P. Clackson, Co's CEO, Effective As Of Dec 7